IP Library › Assignment 026329/0262
Patent Assignment
Reel/Frame 026329/0262

Assignment of Assignor's Interest

Recorded: 2011-01-31 Pages: 7
Assignor
LOIBNER, HANS
Executed: 2001-02-01
Assignee
IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
RUNNER STRASSE 69, OBJEKT, 3, WIEN, A-1230, AUSTRIA
Covered Properties (2)
N-Glycosylated Antibody
Patent: 7,759,464 →
Application: 11/571,983 →
Publication: US 2008/0095783
Method of Treating Lewis Y-Expressing Tumors
Patent: 8,323,650 →
Application: 12/786,378 →
Publication: US 2011/0020331
Related Assignments (10)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 24, 2010
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 024432/0525 →
Certificate of Appointment May 24, 2010
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 024432/0534 →
Assignment of Assignor's Interest May 24, 2010
From: SCHUSTER, MANFRED; HIMMLER, GOTTFRIED; WAXENECKER, GUNTER; MUDDE, GEERT C.
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024432/0613 →
Assignment of Assignor's Interest May 24, 2010
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: GREENOVATION BIOTECH GMBH; VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Reel/Frame 024432/0635 →
Assignment of Assignor's Interest Jun 4, 2010
From: SCHUSTER, MANFRED; HIMMLER, GOTTFRIED; WAXENECKER, GUENTER; MUDDE, GEERT C.
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 024489/0676 →
Certificate of Appointment Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: HOCHEGGER, HERBERT, DR.
Reel/Frame 025671/0795 →
Change of Name Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
Reel/Frame 025672/0254 →
Assignment of Assignor's Interest Jan 20, 2011
From: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-GMBH
To: GREENOVATION BIOTECH GMBH; VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
Reel/Frame 025672/0410 →
Assignment of Assignor's Interest Jan 20, 2011
From: VELA PHARMAZEUTISCHE ENTWICKLUNG UND LABORANALYTIK GMBH
To: MERIDIAN BIOPHARMACEUTICALS GMBH
Reel/Frame 025672/0418 →
Consulting Agreement Jan 31, 2011
From: LOIBNER, HANS
To: IGENEON KREBS-IMMUNTHERAPIE FORSCHUNGS-UND ENTWICKLUNGS-AG
Reel/Frame 025722/0761 →